Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia - 05/08/11
, Anne C. Goldberg, MD b, Howard R. Knapp, MD, PhD c, Maureen T. Kelly, MD d, Carolyn M. Setze, MS d, James C. Stolzenbach, PhD d, Darryl J. Sleep, MD dRésumé |
Background |
Statin and ezetimibe combination therapy may be insufficient to improve lipid and nonlipid parameters beyond low-density lipoprotein cholesterol (LDL-C) in patients with mixed dyslipidemia.
Methods |
In this phase 3, multicenter, double-blind study, a total of 543 patients with triglycerides ≥150 mg/dL and <400 mg/dL, high-density lipoprotein cholesterol (HDL-C) <40 mg/dL (<50 mg/dL for women), and LDL-C ≥130 mg/dL were randomized to 12 weeks of treatment with fenofibric acid 135 mg (FA) or placebo, each coadministered with atorvastatin 40 mg + ezetimibe 10 mg (Atorva/Eze).
Results |
Both treatment regimens lowered LDL-C by >50%; however, FA + Atorva/Eze resulted in significantly (P < .001) greater improvements in HDL-C (13.0% vs 4.2%), triglycerides (−57.3% vs −39.7%), non–HDL-C (−55.6% vs −51.0%), and apoprotein B (−49.1% vs −44.7%) compared with Atorva/Eze. Overall, adverse events were similar in the 2 treatment groups. No unexpected muscle, hepatic, or renal safety signals were identified with either treatment combination.
Conclusions |
In patients with mixed dyslipidemia, the combination of FA + Atorva/Eze significantly improved lipid and nonlipid parameters compared with Atorva/Eze and was generally well tolerated.
Le texte complet de cet article est disponible en PDF.Plan
| RCT reg #NCT00639158. |
Vol 160 - N° 4
P. 759-766 - octobre 2010 Retour au numéro
Article précédent
- Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: Results from an observational registry
- Matthew R. Reynolds, Edith Morais, Peter Zimetbaum
- Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era
- John J. Lopez, Michelle J. Keyes, Sandeep Nathan, Robert Piana, Michael Pencina, Gaurav Dhar, Steven Marso, Sunil Rao, Salim Shammo, Walt Marquardt, David J. Cohen, Neal S. Kleiman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?